James L. Januzzi

3.3k total citations · 2 hit papers
59 papers, 1.5k citations indexed

About

James L. Januzzi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, James L. Januzzi has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 15 papers in Surgery and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in James L. Januzzi's work include Heart Failure Treatment and Management (15 papers), Cardiovascular Function and Risk Factors (14 papers) and Acute Myocardial Infarction Research (8 papers). James L. Januzzi is often cited by papers focused on Heart Failure Treatment and Management (15 papers), Cardiovascular Function and Risk Factors (14 papers) and Acute Myocardial Infarction Research (8 papers). James L. Januzzi collaborates with scholars based in United States, Canada and United Kingdom. James L. Januzzi's co-authors include Richard W. Troughton, G. Michael Felker, Anju Bhardwaj, Dave L. Dixon, Gurusher Panjrath, Anita Deswal, M. Kittleson, Kaushik Amancherla, Leslie L. Davis and Clyde W. Yancy and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The FASEB Journal.

In The Last Decade

James L. Januzzi

54 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction

2023 209 citations M. Kittleson, Gurusher Panjrath et al. Journal of the American College of Cardiology profile →
Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates

2022 171 citations Reza Mohebi, Nasrien E. Ibrahim et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by James L. Januzzi

Since Specialization

Citations

This map shows the geographic impact of James L. Januzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Januzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Januzzi more than expected).

Fields of papers citing papers by James L. Januzzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Januzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Januzzi. The network helps show where James L. Januzzi may publish in the future.

Co-authorship network of co-authors of James L. Januzzi

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Januzzi. A scholar is included among the top collaborators of James L. Januzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Januzzi. James L. Januzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perspective on the Choice and Duration of Dual Antiplatelet Therapy Recommendations in the 2025 Acute Coronary Syndrome Management Guideline 2025 ·Journal of the American College of Cardiology ·Dennis T. Ko, Rasha Al‐Lamee, Behnood Bikdeli, David J. Cohen, James L. Januzzi, Mitsuaki Sawano, Erica S. Spatz, Seng Chan You	0
2	Impact of Canagliflozin on Heart Stress and Outcomes: Pooled Insights from CREDENCE and CANVAS 2025 ·European Journal of Heart Failure ·Antoni Bayés‐Genís, (unknown), Yuxi Liu, Ambarish Pandey, Rodica Pop‐Busui, (unknown), James L. Januzzi	1
3	Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions 2025 ·The American Journal of Cardiology ·(unknown), Cian P. McCarthy, Craig A. Magaret, (unknown), Farouc A. Jaffer, James L. Januzzi	1
4	The Role of Lactate Metabolism in Heart Failure and Cardiogenic Shock: Clinical Insights and Therapeutic Implications 2025 ·Journal of Cardiac Failure ·Melana Yuzefpolskaya, (unknown), (unknown), Jacob Abraham, Chris P Gale, (unknown), Liviu Klein, David T. Majure, (unknown), Farooq H. Sheikh, P.C. Colombo, James L. Januzzi, Ezequiel Molina	7
5	Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial 2025 ·Cardiovascular Diabetology ·Thomas H. Marwick, (unknown), Yuxi Liu, Stefano Del Prato, Julio Rosenstock, Javed Butler, Justin A. Ezekowitz, Nasrien E. Ibrahim, Wen Tang, Faı̈ez Zannad, Riccardo Perfetti, James L. Januzzi	2
6	Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced prediction 2024 ·Nature Cardiovascular Research ·Art Schuermans, (unknown), Jiwoo Lee, (unknown), (unknown), (unknown), Aeron Small, Zhi Yu, Whitney Hornsby, Satoshi Koyama, Charles Kooperberg, Alexander P. Reiner, James L. Januzzi, Michael C. Honigberg, Pradeep Natarajan	15
7	Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes 2024 ·Journal of the American College of Cardiology ·Kershaw V. Patel, (unknown), Subodh Verma, Matthew W. Segar, Katelyn R Garcia, Chiadi E. Ndumele, Thomas J. Wang, James L. Januzzi, Antoni Bayés‐Genís, Javed Butler, Carolyn S.P. Lam, Christie M. Ballantyne, James A. de Lemos, Alain G. Bertoni, Mark A. Espeland, Ambarish Pandey	4
8	Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases 2023 ·Journal of Diabetes and its Complications ·Yehuda Handelsman, Javed Butler, George L. Bakris, Ralph A. DeFronzo, Gregg C. Fonarow, Jennifer B. Green, George Grunberger, James L. Januzzi, Samuel Klein, Pamela Kushner, Darren K. McGuire, Erin D. Michos, Javier Morales, Richard E. Pratley, Matthew R. Weir, Eugene E. Wright, Vivian Fonseca	43
9	Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study 2023 ·Journal of Cardiac Failure ·Alaa Mabrouk Salem Omar, Sean Murphy, G. Michael Felker, Ileana L. Piña, (unknown), Yuxi Liu, (unknown), (unknown), Jonathan H. Ward, Kristin Williamson, Scott Solomon, James L. Januzzi, Johanna Contreras	0
10	Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial Infarction 2023 ·Journal of the American College of Cardiology ·Cian P. McCarthy, Seán Murphy, (unknown), Paula Rambarat, (unknown), Yuxi Liu, Reza Mohebi, A.P. Levin, Avanthi Raghavan, (unknown), Campbell Rogers, Jason H. Wasfy, Ron Blankstein, Brian Ghoshhajra, Sandeep Hedgire, James L. Januzzi	5
11	2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction breakdown → 2023 ·Journal of the American College of Cardiology ·M. Kittleson, Gurusher Panjrath, Kaushik Amancherla, Leslie L. Davis, Anita Deswal, Dave L. Dixon, James L. Januzzi, Clyde W. Yancy	209
12	ASSOCIATION BETWEEN ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION, CARDIOVASCULAR BIOMARKERS AND CARDIAC REMODELING IN HEART FAILURE WITH REDUCED EJECTION FRACTION 2021 ·Journal of the American College of Cardiology ·Sean Murphy, Margaret F. Prescott, Alan Maisel, Javed Butler, Ileana L. Piña, G. Michael Felker, Jonathan H. Ward, Kristin Williamson, (unknown), (unknown), Scott D. Solomon, James L. Januzzi	0
13	CLINICAL PHENOGROUPS ARE MORE EFFECTIVE THAN LEFT VENTRICULAR EJECTION FRACTION CATEGORIES IN STRATIFYING HEART FAILURE OUTCOMES 2021 ·Journal of the American College of Cardiology ·Andreas B. Gevaert, (unknown), Mamas Mamas, Neal G. Ravindra, Shun Fu Lee, Tariq Ahmad, Dennis T. Ko, James L. Januzzi, (unknown)	5
14	Management of Low Blood Pressure in Ambulatory Heart Failure with Reduced Ejection Fraction Patients 2020 ·European Journal of Heart Failure ·Jennifer Cautela, Jean‐Michel Tartière, Alain Cohen‐Solal, (unknown), Alexis Théron, (unknown), James L. Januzzi, François Roubille, Nicolas Girerd	63
15	CONTEMPORARY ETIOLOGIES, TREATMENT STRATEGIES, AND OUTCOMES OF LEFT VENTRICULAR THROMBUS 2019 ·Journal of the American College of Cardiology ·(unknown), Sean Murphy, Ramkumar Venkateswaran, Avinainder Singh, Leslie Chang, (unknown), Arman Qamar, Muthiah Vaduganathan, James L. Januzzi, Deepak L. Bhatt	6
16	LONGITUDINAL CHANGES IN MULTIPLE BIOMARKERS ARE ASSOCIATED WITH CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH DOXORUBICIN, TAXANES AND TRASTUZUMAB 2015 ·Journal of the American College of Cardiology ·Virginia S. Hahn, Mary Putt, Heloisa Sawaya, James L. Januzzi, Igal A. Sebag, Juan Carlos Plana, Michael H. Picard, Robert E. Gerszten, Elkan F. Halpern, Irene Kuter, Randolph P. Martin, Joseph R. Carver, Marielle Scherrer‐Crosbie, Bonnie Ky	4
17	Amino-terminal Pro-brain Natriuretic Peptide Testing – Recent Lessons Learned 2006 ·European Cardiology Review ·James L. Januzzi	1
18	1042-80 Ischemia modified albumin improves the sensitivity and negative predictive value of standard cardiac biomarkers for the diagnosis of myocardial ischemia 2004 ·Journal of the American College of Cardiology ·Saif Anwaruddin, James L. Januzzi, Kent Lewandrowski, Elizabeth Lee Lewandrowski	1
19	Characterizing the young patient with aortic dissection: Results from the International Registry of Aortic Dissection (IRAD) 2003 ·Journal of the American College of Cardiology ·James L. Januzzi, Eric M. Isselbacher, (unknown), Jeanna V. Cooper, Dean E. Smith, Kim A. Eagle, Christoph Nienaber, Linda Pape	32
20	Heparin Induced Thrombocytopenia: Diagnosis and Contemporary Antithrombin Management 1999 ·Journal of Thrombosis and Thrombolysis ·James L. Januzzi, Ik–Kyung Jang	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact